Ultragenyx Pharmaceutical... (RARE)
NASDAQ: RARE
· Real-Time Price · USD
29.68
0.67 (2.31%)
At close: Aug 15, 2025, 3:59 PM
29.87
0.62%
After-hours: Aug 15, 2025, 07:57 PM EDT
Ultragenyx Pharmaceutical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -532.93M | -549.58M | -569.18M | -558.99M | -585.12M | -613.35M | -606.64M | -635.28M | -720.74M | -719.07M | -707.42M | -678.05M | -505.94M | -470.2M | -454.02M | -355.58M | -351.43M | -203.68M |
Depreciation & Amortization | -21.23M | -594K | -739K | -1.6M | 33.12M | 29.61M | 26.01M | 22.75M | 20.25M | 19.37M | 18.22M | 16.8M | 15.32M | 13.96M | 13.24M | 12.84M | 12.71M | 12.78M |
Stock-Based Compensation | 160.18M | 161.01M | 158.02M | 151.6M | 144.91M | 140.2M | 135.23M | 130.84M | 131.72M | 132.93M | 130.38M | 127.84M | 118.87M | 110.09M | 104.95M | 100.97M | 94.52M | 89.83M |
Other Working Capital | 58.56M | 34.09M | 58.12M | 10.65M | 2.92M | 22.04M | 13.49M | 15.23M | 16.11M | 2.81M | 10.73M | -20.56M | -38.16M | -58.15M | -116.2M | -109.31M | -130.1M | -120.54M |
Other Non-Cash Items | -80.85M | 19.65M | 134.71M | 276.01M | 252.53M | 228.72M | 129.61M | 13.39M | 102.36M | 115.04M | 119.76M | 111.66M | 28.48M | 19.84M | 11.71M | 18.67M | 19.9M | 20.87M |
Deferred Income Tax | n/a | n/a | n/a | -139.17M | -140.43M | -143.91M | -143.91M | -6.38M | -5.12M | -1.64M | -1.64M | 18.21M | -5.51M | 27.11M | 48.67M | -48.35M | -12.61M | -140.72M |
Change in Working Capital | 53.58M | 13.3M | 13.92M | 4.47M | -23.56M | -32.76M | -15.1M | -6.56M | 12.81M | 33.56M | 60.23M | 59.08M | 40.01M | 2.33M | -63.24M | -75.35M | -112.22M | 24.52M |
Operating Cash Flow | -421.25M | -389.94M | -414.19M | -418.59M | -469.47M | -508.67M | -474.81M | -481.24M | -458.71M | -419.81M | -380.46M | -344.47M | -308.77M | -296.87M | -338.69M | -346.8M | -349.12M | -196.41M |
Capital Expenditures | -6.05M | -23.1M | -19.99M | -20.94M | -23.02M | -34.94M | -46.77M | -72.14M | -94.49M | -108.97M | -146.12M | -135.2M | -129.72M | -118.86M | -73.09M | -76.72M | -62.21M | -46.22M |
Cash Acquisitions | n/a | n/a | n/a | 2.5M | 2.5M | n/a | n/a | -2.13M | -77.53M | -75.03M | -75.03M | 4.45M | 79.84M | 79.84M | 79.84M | 2.27M | 4.55M | 4.55M |
Purchase of Investments | -398.81M | -386.69M | -408.61M | -614.27M | -386.38M | -486.29M | -526.38M | -503.36M | -574.76M | -470.59M | -614.74M | -510.94M | -553.12M | -813.13M | -1.01B | -1.11B | -1.05B | -970.3M |
Sales Maturities Of Investments | 439.59M | 418.63M | 413.27M | 410.27M | 524.48M | 675.52M | 746.2M | 683.93M | 626.67M | 518.98M | 545.08M | 671.23M | 753.94M | 880.04M | 890.85M | 1.02B | 894.95M | 755.66M |
Other Investing Acitivies | -16.42M | -16.15M | -2.44M | -2.58M | -2.81M | -662K | -2.55M | -2.88M | -2.63M | -7.37M | -844K | -80.54M | -80.85M | -99.38M | -267.97M | -193.62M | -197.29M | -258.17M |
Investing Cash Flow | 18.3M | 7.69M | -17.77M | -227.52M | 112.28M | 151.13M | 168M | 103.42M | -122.74M | -142.99M | -291.65M | -51M | 70.1M | -50.31M | -195.37M | -166.53M | -221.53M | -266.42M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 58K | n/a | n/a | n/a | -58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 14.26M | 395.28M | 395.07M | 396.04M | 389.48M | 37.56M | 36.89M | 34.62M | 526.06M | 498.87M | 499.45M | 504.35M | 20.03M | 26.82M | 39.61M | 86.98M | 98.57M | 121.75M |
Financial Cash Flow | 98.17M | 399.46M | 399.24M | 726.66M | 740.73M | 388.81M | 388.14M | 59.41M | 526.06M | 498.87M | 501.21M | 585.05M | 100.72M | 107.52M | 118.55M | 522.54M | 534.12M | 557.31M |
Net Cash Flow | -298.22M | 20.63M | -31.43M | 89.47M | 387.06M | 34.89M | 85.85M | -317.7M | -55.05M | -64.68M | -171.98M | 186.77M | -140.16M | -240.2M | -416.71M | 9.29M | -35.53M | 95.44M |
Free Cash Flow | -427.3M | -413.04M | -434.18M | -439.53M | -492.48M | -543.61M | -521.57M | -553.38M | -553.2M | -528.78M | -526.59M | -479.67M | -438.49M | -415.73M | -411.79M | -423.52M | -411.33M | -242.64M |